Press Release: MVision AI is selected to provide its Contour+ solution by the Republic of Ireland’s Health Service Executive (HSE) for its first installation in the country

HELSINKI, Finland – September 14, 2023

MVision AI is experiencing ongoing and rapid growth within the health service sector globally. The company is delighted to announce that we have successfully been awarded the tender from the Republic of Ireland’s Health Service Executive (HSE) for the installation of our Contour+ auto contouring solution at Cork University Hospital.

“MVision AI are truly delighted to have been selected as the preferred supplier of an AI auto contouring system to Cork University Hospital. This will be the first deployment of our Guideline Based Contour+ solution via our Cloud service within this country,” says Stewart Pegrum, MVision AI’s Vice President of Global Sales.

The procurement was undertaken via a national EU tender process, which was published on 3rd February 2023 Each tender applicant was evaluated on Qualitative Selection Criteria including; Economic and Financial Standing, Technical and Professional Ability and Quality Assurance Standards.

Tenders that achieve the minimum requirements set out in the Qualitative Selection Criteria were then evaluated to determine which presented the most economically advantageous tender using the award criteria below:

Project Management & Installation (5%)

Primary Requirements (5%)

Functional Requirements (10%)

Clinical Requirements (25%)

ICT Technical Requirements (10%)

Service & Support (5%)

Training & Documentation (5%)

Sustainability (5%)

Cost (30%)

As part of the clinical requirements sample delineations for a selection of structures were requested for evaluation purposes from the Tenderers. These were reviewed by the tender panel that was made up of Medical Physicists, Radiation Oncologists, Radiation therapists and HSE procurement representatives.

We recently started SABR Lung treatments and expect to introduce SABR Liver and SRS treatments in the near future. We hope MVision AI will help us to standardize contouring in line with best practice guidelines and reduce the time spent delineating patient datasets by approximately 50%,” says Mr. Michael Roche, Principal Physicist, Medical Physics Department in Cork University Hospital. 

MVision AI’s interests in the UK and Ireland are represented by our longstanding distributor, Xiel, which specializes in providing solutions for Nuclear Medicine, Radiotherapy, and Diagnostic Radiology.

“We are delighted that CUH have selected MVision AI as their solution for auto contouring, this was a very stringent process with much interaction and this award demonstrates the robust capabilities of Contour +”, says Phil Neale, Xiel’s Key Account Consultant in Radiotherapy Physics.

About MVision AI

MVision AI is an innovative software service provider for radiotherapy treatment planning. Our AI-powered automatic segmentation tool, Contour+, helps to standardize contouring and automate segmentation to streamline the radiotherapy treatment planning workflow.

MVision.ai

MVision AI Linkedin page

MVision AI Media Kit

About Cork University Hospital (CUH)

Currently Cork University Hospital (CUH) treats c.2000 patients annually. At present, the majority of volume delineation is a time-consuming process and is manually performed by CUH’s 7 Consultant Radiation Oncologists  who may be assisted at times by other staff members including Dosimetrists or Radiation Therapists. A new radiotherapy facility was opened in 2019.
CUH.hse.ie

Cork University Hospitals Linkedin Group

About Xiel. 

Xiel is a specialist distributor of medical technologies in the UK and Ireland. We work with global leading solution providers; therefore, continuously improving efficiency and quality for our customers. Our partners research and develop highly specific products for what is often a small world market. The expertise of Xiel lies in our deep understanding of the structure and organisation of radiotherapy departments in the UK and Ireland, for us to advise on the best solutions possible. Xiel. Exceptional Products. Extraordinary Service. Everyday.

Xiel.co.uk

Xiel Linkedin page

 

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

26.8.2024

Lung Cancer Awareness–Examining Tobacco’s Effect

As August comes to a close, we take a moment to reflect on World Lung Cancer Day, observed earlier this month. This year’s focus has underscored the critical fact that tobacco smoking remains the leading cause of lung cancer. Understanding this connection is essential for both prevention and treatment, emphasizing…

News

6.8.2024

MVision AI Secures CDSCO Approval to Revolutionize Cancer Treatment Planning in India

HELSINKI, Finland – August, 2024 MVision AI is excited to announce that our application for MVision AI Segmentation (Contour+) has been approved by the Central Drugs Standard Control Organization (CDSCO) under the “Image Segmentation Application Software” category. This approval facilitates the deployment of our advanced image analysis algorithms in radiation…

Press Releases

2.7.2024

Breaking New Ground: MVision AI Contour+ for Upright MRI Scans

Results on testing MVision AI Contour+ for an ingenious and modern approach in radiation therapy have been recently presented at the 62nd Particle Therapy Co-Operative Group (PTCOG) conference in Singapore. Despite being trained using supine MR data and a different magnetic strength from different scanners, authors reported that MVision AI's…

Articles